Biotech Values

[DewDiligence]

…the Arbutus trial—[w IFN]—will yield some positive results—but the evidence that they are using interferon suggests that this is NOT the final iteration of success, and in a way is admitting that they don't possess a strong enough antiviral to achieve a formidable treatment.

I concur.